PROGESTASERT Drug Patent Profile
✉ Email this page to a colleague
When do Progestasert patents expire, and when can generic versions of Progestasert launch?
Progestasert is a drug marketed by Alza and is included in one NDA.
The generic ingredient in PROGESTASERT is progesterone. There are fifty-seven drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the progesterone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Progestasert
A generic version of PROGESTASERT was approved as progesterone by FRESENIUS KABI USA on April 25th, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROGESTASERT?
- What are the global sales for PROGESTASERT?
- What is Average Wholesale Price for PROGESTASERT?
Summary for PROGESTASERT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 116 |
| Patent Applications: | 4,284 |
| DailyMed Link: | PROGESTASERT at DailyMed |
US Patents and Regulatory Information for PROGESTASERT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alza | PROGESTASERT | progesterone | INSERT, EXTENDED RELEASE;INTRAUTERINE | 017553-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
